During the past decade, Allied Biomedical Research Institute conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 5 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Allied Biomedical Research Institute" #1 sponsor was "AstraZeneca" with 2 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Cognition Therapeutics" with 1 trials sponsored, "Currax Pharmaceuticals" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Allied Biomedical Research Institute" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Clinilabs, Inc." with 1 trials as a collaborator, "Grifols Biologicals, LLC" with 1 trials as a collaborator and "National Institute on Aging (NIA)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Allied Biomedical Research Institute" are "Alzheimer Disease" (5 trials), "Alzheimer's Disease" (3 trials), "Acute Migraine With or Without Aura" (1 trials), "Agitation" (1 trials) and "Alzheimer's Type Dementia" (1 trials). Many other conditions were trialed in "Allied Biomedical Research Institute" in a lesser frequency.

Most popular intervention types in "Allied Biomedical Research Institute" are "Drug" (18 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Gantenerumab" (2 trials), "Lanabecestat" (2 trials), "15mg T3D-959" (1 trials) and "30 mg T3D-959" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allied Biomedical Research Institute" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Allied Biomedical Research Institute". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Allied Biomedical Research Institute, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Allied Biomedical Research Institute, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".